NSP Pharma Corp. Obtains Approval for Change of Year End.PICKERING, Ontario -- Sergio Martines, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of NSP Pharma Corp. ("NSP")(TSX VENTURE:NSP) announces that NSP has received approval from the Ontario Securities Commission The Ontario Securities Commission (OSC) is a regulatory agency which administers and enforces securities legislation in the Canadian province of Ontario. The OSC is an Ontario Crown corporation which reports to the Ontario legislature through the Minister of Finance. to change its fiscal year end from June 30 to December 31, commencing December 31, 2005. This change will enable both NSP and Naturale Science Pharma Inc., NSP's wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. to have coincidental fiscal year ends. NSP expects to report and publish the financial statements for the six month period ended December 31, 2005 and all other required filings by April 30, 2006. About NSPI NSPI National Spa and Pool Institute NSPI National Spa & Pool Institute NSPI Name Service Provider Interface (Microsoft) NSPI Nova Scotia Power Incorporated NSPI National Society of Performance and Instruction NSPI (www.nsp.ca, www.modeleskincare.com) is a leading cosmeceutical cos·me·ceu·ti·cal n. A cosmetic that has or is purported to have medicinal properties. and pharmaceutical company that markets innovative, high-quality, anti-aging products to retail drug and department chains in the United States and Canada. Its objective is to become the premier supplier of skincare and healthcare solutions to an aging global population. Based in Pickering, Ontario and employing 21 people, NSPI's Modele(TM) product line is currently sold in more than 12,200 retail pharmacies and department stores across North America. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. Statements made in this release are accurate as of the time of their release and may not reflect future circumstances. Should unforeseen risks or uncertainties materialize, or should assumptions underlying the forward-looking statements prove incorrect, NSP reserves the right to update and amend the statements contained herein. Shares Outstanding: 15,619,390 Closing Price March 8, 2006: $0.93 The TSX Venture Exchange TSX Venture Exchange Originally called the Canadian Venture Exchange (CDNX), this was a result of the merger of the Vancouver and Alberta stock exchanges. The goal of TSX Venture Exchange is to provide venture companies with effective access to capital while protecting investors. has not reviewed and does not accept resp onsibility for the adequacy or accuracy of this release. NSP Pharma Corp. (TSX VENTURE:NSP) |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion